Clinical trial
Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats
NCT03597438 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 7, 2018
- Completion date
- February 22, 2024
- Enrollment
- 236 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitochondrial alteration